Latest News and Press Releases
Want to stay updated on the latest news?
-
New York, N.Y., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”), a developer of platelet-derived and plant-based exosome therapeutics and diagnostics, today announced...
-
Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Middle East Exosomes Market Size, Share & Trends Analysis Report by Product & Service (Kits & Reagents, Instruments, Services), Workflow...
-
EVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseases
-
EVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseases to launch its first clinical trial of EVerGel™ in 2026.
-
Dublin, July 18, 2025 (GLOBE NEWSWIRE) -- The "Exosome Research Market by Offering (Kits, Reagents (Antibodies, Isolation, Purification), Instruments, Services), Indication (Cancer, Infectious...
-
Dublin, June 25, 2025 (GLOBE NEWSWIRE) -- The "Extracellular Vesicles/Exosomes Asia 2025" conference has been added to ResearchAndMarkets.com's offering. The Extracellular Vesicles/Exosomes Asia...
-
Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Exosomes- Pipeline Insight, 2025" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about...
-
Dublin, April 11, 2025 (GLOBE NEWSWIRE) -- The "Exosome Research Market by Product Type (Instruments & Software, Isolation Kits, Purification Kits), Method (Filtration, Microfluidics,...
-
Dublin, March 19, 2025 (GLOBE NEWSWIRE) -- The "Exosome Therapeutics Market Industry Trends and Global Forecasts to 2035, by Type of Therapeutic, Target Indication, Therapeutic Area, Route of...
-
Dublin, March 14, 2025 (GLOBE NEWSWIRE) -- The "Innovation Insights: Engineered Exosomes" report has been added to ResearchAndMarkets.com's offering. In the Engineered Exosome drug deals, there...